11/14/2024
6:54 PM | Iterum Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:10 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
5:24 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
10/28/2024
5:06 AM | Iterum Therapeutics (Filer)
| Form 424B5 | |
10/25/2024
10:20 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/15/2024
7:00 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
8:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:20 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
3:15 PM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/30/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/24/2024
7:59 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/24/2024
8:01 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/23/2024
5:30 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/11/2024
3:50 PM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
09/09/2024
5:15 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
08/14/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
08/12/2024
8:00 AM | HUNT RONALD (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:00 AM | Fishman Corey N. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:00 AM | Dunne Michael W. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
4:28 PM | Iterum Therapeutics (Filer)
| Form POS AM | |
08/06/2024
4:25 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2024
3:30 PM | Iterum Therapeutics (Filer)
| Form PRE 14A | |
07/22/2024
7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2024
11:15 PM | Iterum Therapeutics (Filer)
| Form EFFECT | |
07/19/2024
4:05 PM | Iterum Therapeutics (Filer)
| Form 424B3 | |
07/17/2024
3:21 PM | Iterum Therapeutics (Filer)
| Form S-1/A | |
06/26/2024
4:24 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
4:27 PM | Iterum Therapeutics (Filer)
| Form S-1/A | |
06/21/2024
7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:11 PM | Iterum Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
05/31/2024
7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form ARS | |
04/26/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024
6:00 AM | Iterum Therapeutics (Filer)
| Form DEF 14A | |
04/05/2024
3:30 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad) As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential.
Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! |
03/29/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
6:30 AM | Iterum Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
7:16 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
3:55 PM | Iterum Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
01/30/2024
4:00 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
6:15 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
3:30 PM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
8:00 AM | Dunne Michael W. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
6:45 AM | Iterum Therapeutics (Filer)
| Form DEFA14A | |
12/14/2023
6:30 AM | Iterum Therapeutics (Filer)
| Form DEF 14A | |
12/04/2023
4:15 PM | Iterum Therapeutics (Filer)
| Form PRE 14A | |
12/04/2023
7:30 AM | Iterum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2023
4:00 PM | Dunne Michael W. (Reporting)
Iterum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
